Sopharma AD

BUL:SFA Stock Report

Market Cap: €1.0b

Sopharma AD Balance Sheet Health

Financial Health criteria checks 4/6

Sopharma AD has a total shareholder equity of BGN981.4M and total debt of BGN511.1M, which brings its debt-to-equity ratio to 52.1%. Its total assets and total liabilities are BGN2.0B and BGN1.0B respectively. Sopharma AD's EBIT is BGN120.6M making its interest coverage ratio 7.6. It has cash and short-term investments of BGN32.7M.

Key information

52.08%

Debt to equity ratio

лв511.08m

Debt

Interest coverage ratio7.6x
Cashлв32.65m
Equityлв981.36m
Total liabilitiesлв1.04b
Total assetsлв2.02b

Recent financial health updates

Recent updates

There May Be Underlying Issues With The Quality Of Sopharma AD's (BUL:SFA) Earnings

Sep 06
There May Be Underlying Issues With The Quality Of Sopharma AD's (BUL:SFA) Earnings

Sopharma AD's (BUL:SFA) Dividend Will Be BGN0.08

Jul 03
Sopharma AD's (BUL:SFA) Dividend Will Be BGN0.08

Is Sopharma AD (BUL:SFA) A Risky Investment?

Jul 01
Is Sopharma AD (BUL:SFA) A Risky Investment?

Sopharma AD's (BUL:SFA) Problems Go Beyond Weak Profit

Sep 07
Sopharma AD's (BUL:SFA) Problems Go Beyond Weak Profit

Here's Why Sopharma AD (BUL:SFA) Can Manage Its Debt Responsibly

Jun 02
Here's Why Sopharma AD (BUL:SFA) Can Manage Its Debt Responsibly

Sopharma AD (BUL:SFA) Has A Somewhat Strained Balance Sheet

Apr 09
Sopharma AD (BUL:SFA) Has A Somewhat Strained Balance Sheet

Here's Why We Think Sopharma AD (BUL:3JR) Is Well Worth Watching

Feb 20
Here's Why We Think Sopharma AD (BUL:3JR) Is Well Worth Watching

How Many Sopharma AD (BUL:3JR) Shares Do Institutions Own?

Feb 05
How Many Sopharma AD (BUL:3JR) Shares Do Institutions Own?

Should You Rely On Sopharma AD's (BUL:3JR) Earnings Growth?

Jan 22
Should You Rely On Sopharma AD's (BUL:3JR) Earnings Growth?

Sopharma AD (BUL:3JR) Has A Somewhat Strained Balance Sheet

Jan 06
Sopharma AD (BUL:3JR) Has A Somewhat Strained Balance Sheet

Sopharma AD (BUL:3JR) Share Prices Have Dropped 25% In The Last Three Years

Dec 22
Sopharma AD (BUL:3JR) Share Prices Have Dropped 25% In The Last Three Years

Should Sopharma AD (BUL:3JR) Be Part Of Your Dividend Portfolio?

Dec 07
Should Sopharma AD (BUL:3JR) Be Part Of Your Dividend Portfolio?

Are Investors Undervaluing Sopharma AD (BUL:3JR) By 29%?

Nov 19
Are Investors Undervaluing Sopharma AD (BUL:3JR) By 29%?

Financial Position Analysis

Short Term Liabilities: SFA's short term assets (BGN1.0B) exceed its short term liabilities (BGN791.4M).

Long Term Liabilities: SFA's short term assets (BGN1.0B) exceed its long term liabilities (BGN245.1M).


Debt to Equity History and Analysis

Debt Level: SFA's net debt to equity ratio (48.8%) is considered high.

Reducing Debt: SFA's debt to equity ratio has reduced from 62.7% to 52.1% over the past 5 years.

Debt Coverage: SFA's debt is not well covered by operating cash flow (3.6%).

Interest Coverage: SFA's interest payments on its debt are well covered by EBIT (7.6x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/19 21:45
End of Day Share Price 2026/01/19 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sopharma AD is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.